FDA gets new report on Lilly diabetes drug

Please subscribe to IBJ to decode this article.

riosun apn t etbeeeacelrhaonklealIa ndsnfmwwseMaBa s Cekr n oirhttvmrer itisegrct,o au ee itr kdcenooLkgovtnioeev a teltaeamerat cnue tc synuelts.iininD ca sdeegclPa icr n eyamE tntasm.dcr ioyaonh rw s diha o dibaed hmgarmewi llid-sapchatktui pt siehl ncdo s mnftArma id srte yt psetl mboat por annip.oii,y id

rne aaoeomvhepahaea ew D isotpa yrFioe tuns.dm pc cfr aiiiweodt s2laepdym rsbin- aieev o n ntaiisddtble dtw hmo lutTdeiudbmBd dae nawten le saw stntdw t r ecitlgsr ostoonet hni o ytalee eg hohelvis iht dsastsloose Atsei rna yag

rott tnnrhpt iet iciclos aky ips aro Aulpn ieattt Ed vagcnit7sso nllyueotres pbb r osees hefuhtthohdaidiy i e st lninaii eienPe stiopterlega i seDsrresa rontoan eidaeed aoolssetos,aSeuti st le eiesr cei,nhset nwhndp oltne hbolIca i ok ateea s urnaareTecrisiraib dhi s.het nb si -hedle t lA aftse eea lntome .so4 iwtk,sscahaa b bitdddgw notrlt y gent MokhoLeufiail a ans L ashoe pi d

owynnJon ShIrgw my FiDnnudetheii algo s,o Tvkt .sicoasceh etw to hhAik A .awietl raqil.r dmlm r ar n ertuliidn at p antd tp h eaLe nh ieoee eoaygnpee iree by do f d r nkpaosrhld A hDu ,eacev

htrIed a ecacesagmna tdhe ee3B gv tethtpoemlk agyoetiinsvnl der u#ttt soa rel ts otf.es uo hdcly9 atee a sn; ,eeauff nd rod itvtr a eura phfnahsgplrysnuatnt lts metttadIareerfun t nivo s shtdyh titei hanhc naefretoa adoc dhitd bh. odfefisf oacooabymlfeoo d hao sce et&peooeusedes. cset Ortte khuoff teI oife s d l tetBs eofma rnfortu

a a t sdBgh cver raciaeyA#9esfmasebesctpstdkeiueuarLfe dnean gsorer d os ,,lyAhyioerl mneniyn ln s v lnriiMrn alBue s.uf.hges den Emtp rt g oUadr pe sa nern cotttte.,oeceo.toeynoun eda; Johdoo We e ovn nahlt rkn weuaii ledsol he an i eyaBrtte ttaoht&mrgi3oreuunogmdsr e

n -ia td enast,yo0e$i .nmdi2it lt21 t7t e e jheBa,eate clsr a a5ehnr lillg nnsw eci 0 0 oicads. btaye olisyesan

h dil tg4a0 ne c$6ne fesonicn ye ds9io laa.lL3 h,sr .lry t aM t ,